Synthesis and antileishmanial profile of some novel terpenyl pyrimidines

被引:39
作者
Pandey, S
Suryawanshi, SN [1 ]
Gupta, S
Srivastava, VML
机构
[1] Cent Drug Res Inst, Div Med Chem, Lucknow, Uttar Pradesh, India
[2] Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India
关键词
ionones; terpenyl pyrimidines; antileishmanial activity;
D O I
10.1016/j.ejmech.2004.03.007
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Some novel terpenyl pyrimidine derivatives 2(a-d) and 6(a-b) have been synthesised from alpha/beta-ionone keteneacetals 1 and 5. The terpenyl pyrimidine 2e has been synthesised from P-ionone 3 in two steps in quantitative yield. The pyrimidine derivatives were screened for in-vivo antilesihmanial activity. The compounds 2d, 2e, 6a and 6b showed promising in-vivo antileishmanial activity. (C) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:969 / 973
页数:5
相关论文
共 21 条
[1]  
Alves LV, 2003, BIOL PHARM BULL, V26, P453, DOI 10.1248/bpb.26.453
[2]   Synthesis and antimicrobial activity of heterocyclic ionone-like derivatives [J].
Anzaldi, M ;
Sottofattori, E ;
Rizzetto, R ;
di Casaleto, BG ;
Balbi, A .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1999, 34 (10) :837-842
[3]   Pentamidine isethionate as treatment and secondary prophylaxis for disseminated cutaneous leishmaniasis during HIV infection: Case report [J].
Calza, L ;
Marinacci, G ;
Manfredi, R ;
Colangeli, V ;
Fortunato, L ;
Chiodo, F .
JOURNAL OF CHEMOTHERAPY, 2001, 13 (06) :653-657
[4]   Novel inhibitors of Leishmanial dihydrofolate reductase [J].
Chowdhury, SF ;
Di Lucrezia, R ;
Guerrero, RH ;
Brun, R ;
Goodman, J ;
Ruiz-Perez, LM ;
Pacanowska, DG ;
Gilbert, IH .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (08) :977-980
[5]   Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase [J].
Chowdhury, SF ;
Villamor, VB ;
Guerrero, RH ;
Leal, I ;
Brun, R ;
Croft, SL ;
Goodman, JM ;
Maes, L ;
Ruiz-Perez, LM ;
Pacanowska, DG ;
Gilbert, IH .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (21) :4300-4312
[6]   Chemotherapy of leishmaniasis [J].
Croft, SL ;
Yardley, V .
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (04) :319-342
[7]  
de Carvalho PB, 2002, BRAZ J PHARM SCI, V36, P69
[8]  
DENYSE H, 1993, TETRAHEDRON, V49, P607
[9]  
FASTIER FN, 1962, PHARMACOL REV, V14, P37
[10]  
FIANPOUR MS, 2001, J NAT PRODUCTS, V64, P1398